SEC Form 4 · accession 0001645627-17-000090
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Jul 3, 2017
Accepted (ET)
Jul 7, 2017 · 12:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 3, 2017 | P | 2,000 | $0.0313 | A | 21,503,349 | D | |
| Common Stock | Jul 3, 2017 | P | 2,000 | $0.0315 | A | 21,505,349 | D | |
| Common Stock | Jul 5, 2017 | P | 2,000 | $0.031 | A | 21,507,349 | D | |
| Common Stock | Jul 5, 2017 | P | 1,000 | $0.031 | A | 21,508,349 | D | |
| Common Stock | Jul 5, 2017 | P | 1,000 | $0.0309 | A | 21,509,349 | D | |
| Common Stock | Jul 5, 2017 | P | 1,000 | $0.03 | A | 21,510,349 | D | |
| Common Stock | Jul 5, 2017 | P | 5,000 | $0.0309 | A | 21,515,349 | D | |
| Common Stock | Jul 5, 2017 | P | 2,000 | $0.0309 | A | 21,517,349 | D | |
| Common Stock | Jul 5, 2017 | P | 1,000 | $0.0309 | A | 21,518,349 | D | |
| Common Stock | Jul 5, 2017 | P | 1,000 | $0.0309 | A | 21,519,349 | D | |
| Common Stock | Jul 5, 2017 | P | 2,000 | $0.0302 | A | 21,521,349 | D | |
| Common Stock | Jul 5, 2017 | P | 2,000 | $0.03 | A | 21,523,349 | D | |
| Common Stock | Jul 5, 2017 | P | 2,000 | $0.0299 | A | 21,525,349 | D | |
| Common Stock | Jul 5, 2017 | P | 2,000 | $0.0289 | A | 21,527,349 | D | |
| Common Stock | Jul 5, 2017 | P | 2,000 | $0.0299 | A | 21,529,349 | D |
Table II — derivative securities
No Table II lines on this filing.